Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer

M A MCNURLAN, Steven Darryll Heys, K G M PARK, J Broom, David Stanley Brown, O EREMIN, P J GARLICK

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

1. Rates of protein synthesis have been measured from the incorporation of 57 mg of L-[1-C-13]leucine/kg for 90 min into muscle tissue and colorectal tumours removed at surgery from cancer patients.

2. For the 20 h preceding surgery and during the measurement of protein synthesis, the patients received intravenous saline, conventional intravenous nutrition (0.2 g of N and 103 non-protein kJ/kg body weight) or intravenous nutrition enriched with the branched-chain amino acids leucine, isoleucine and valine (0.2 g of N with 30% from branched-chain amino acids and 103 non-protein kJ/kg body weight).

3. Conventional intravenous nutrition resulted in a significant stimulation of the rate of protein synthesis in both muscle tissue (2.64+/-0.75%/day versus 1.78+/-0.51%/day in saline control, means+/-SD) and tumour tissue (43.9+/-10.3%/day versus 22.6+/-5.6%/day in saline control).

4. Pre-operative nutrition enriched with branched-chain amino acids was less effective than conventional intravenous nutrition in stimulating protein synthesis in both muscle and tumour. The rates of protein synthesis were 2.12+/-0.41%/day in muscle and 33.7+/-5.3%/day in the tumours.

5. The expression of proliferating cell nuclear antigen in sections of the tumours showed changes with intravenous feeding of the two different amino acid mixtures that were similar to the changes in protein synthesis, and these two variables were significantly correlated. This is evidence that feeding with conventional mixtures and mixtures enriched with branched-chain amino acids stimulates tumour growth.

6. In this study the mixture enriched with branched-chain amino acids provided no clear advantage for cancer patients, since a smaller response to branched-chain amino acids was observed in both tumours and host muscle tissue.

Original languageEnglish
Pages (from-to)339-345
Number of pages7
JournalClinical Science
Volume86
Issue number3
Publication statusPublished - Mar 1994

Keywords

  • Branched-chain amino acids
  • cancer
  • isoleucine
  • leucine
  • muscle
  • protein kinetics
  • protein metabolism
  • total parenteral nutrition
  • tumor
  • valine
  • protein-synthesis
  • skeletal-muscle
  • turnover
  • infusion
  • trial
  • <1-C-13>leucine
  • stimulation
  • modulation

Cite this

MCNURLAN, M. A., Heys, S. D., PARK, K. G. M., Broom, J., Brown, D. S., EREMIN, O., & GARLICK, P. J. (1994). Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer. Clinical Science, 86(3), 339-345.

Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer. / MCNURLAN, M A ; Heys, Steven Darryll; PARK, K G M ; Broom, J; Brown, David Stanley; EREMIN, O ; GARLICK, P J .

In: Clinical Science, Vol. 86, No. 3, 03.1994, p. 339-345.

Research output: Contribution to journalArticle

MCNURLAN, MA, Heys, SD, PARK, KGM, Broom, J, Brown, DS, EREMIN, O & GARLICK, PJ 1994, 'Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer', Clinical Science, vol. 86, no. 3, pp. 339-345.
MCNURLAN MA, Heys SD, PARK KGM, Broom J, Brown DS, EREMIN O et al. Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer. Clinical Science. 1994 Mar;86(3):339-345.
MCNURLAN, M A ; Heys, Steven Darryll ; PARK, K G M ; Broom, J ; Brown, David Stanley ; EREMIN, O ; GARLICK, P J . / Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer. In: Clinical Science. 1994 ; Vol. 86, No. 3. pp. 339-345.
@article{bade4b7c5a104df5a211d7b9207c2be0,
title = "Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer",
abstract = "1. Rates of protein synthesis have been measured from the incorporation of 57 mg of L-[1-C-13]leucine/kg for 90 min into muscle tissue and colorectal tumours removed at surgery from cancer patients.2. For the 20 h preceding surgery and during the measurement of protein synthesis, the patients received intravenous saline, conventional intravenous nutrition (0.2 g of N and 103 non-protein kJ/kg body weight) or intravenous nutrition enriched with the branched-chain amino acids leucine, isoleucine and valine (0.2 g of N with 30{\%} from branched-chain amino acids and 103 non-protein kJ/kg body weight).3. Conventional intravenous nutrition resulted in a significant stimulation of the rate of protein synthesis in both muscle tissue (2.64+/-0.75{\%}/day versus 1.78+/-0.51{\%}/day in saline control, means+/-SD) and tumour tissue (43.9+/-10.3{\%}/day versus 22.6+/-5.6{\%}/day in saline control).4. Pre-operative nutrition enriched with branched-chain amino acids was less effective than conventional intravenous nutrition in stimulating protein synthesis in both muscle and tumour. The rates of protein synthesis were 2.12+/-0.41{\%}/day in muscle and 33.7+/-5.3{\%}/day in the tumours.5. The expression of proliferating cell nuclear antigen in sections of the tumours showed changes with intravenous feeding of the two different amino acid mixtures that were similar to the changes in protein synthesis, and these two variables were significantly correlated. This is evidence that feeding with conventional mixtures and mixtures enriched with branched-chain amino acids stimulates tumour growth.6. In this study the mixture enriched with branched-chain amino acids provided no clear advantage for cancer patients, since a smaller response to branched-chain amino acids was observed in both tumours and host muscle tissue.",
keywords = "Branched-chain amino acids, cancer, isoleucine, leucine, muscle, protein kinetics, protein metabolism, total parenteral nutrition, tumor, valine, protein-synthesis, skeletal-muscle, turnover, infusion, trial, <1-C-13>leucine, stimulation, modulation",
author = "MCNURLAN, {M A} and Heys, {Steven Darryll} and PARK, {K G M} and J Broom and Brown, {David Stanley} and O EREMIN and GARLICK, {P J}",
year = "1994",
month = "3",
language = "English",
volume = "86",
pages = "339--345",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer

AU - MCNURLAN, M A

AU - Heys, Steven Darryll

AU - PARK, K G M

AU - Broom, J

AU - Brown, David Stanley

AU - EREMIN, O

AU - GARLICK, P J

PY - 1994/3

Y1 - 1994/3

N2 - 1. Rates of protein synthesis have been measured from the incorporation of 57 mg of L-[1-C-13]leucine/kg for 90 min into muscle tissue and colorectal tumours removed at surgery from cancer patients.2. For the 20 h preceding surgery and during the measurement of protein synthesis, the patients received intravenous saline, conventional intravenous nutrition (0.2 g of N and 103 non-protein kJ/kg body weight) or intravenous nutrition enriched with the branched-chain amino acids leucine, isoleucine and valine (0.2 g of N with 30% from branched-chain amino acids and 103 non-protein kJ/kg body weight).3. Conventional intravenous nutrition resulted in a significant stimulation of the rate of protein synthesis in both muscle tissue (2.64+/-0.75%/day versus 1.78+/-0.51%/day in saline control, means+/-SD) and tumour tissue (43.9+/-10.3%/day versus 22.6+/-5.6%/day in saline control).4. Pre-operative nutrition enriched with branched-chain amino acids was less effective than conventional intravenous nutrition in stimulating protein synthesis in both muscle and tumour. The rates of protein synthesis were 2.12+/-0.41%/day in muscle and 33.7+/-5.3%/day in the tumours.5. The expression of proliferating cell nuclear antigen in sections of the tumours showed changes with intravenous feeding of the two different amino acid mixtures that were similar to the changes in protein synthesis, and these two variables were significantly correlated. This is evidence that feeding with conventional mixtures and mixtures enriched with branched-chain amino acids stimulates tumour growth.6. In this study the mixture enriched with branched-chain amino acids provided no clear advantage for cancer patients, since a smaller response to branched-chain amino acids was observed in both tumours and host muscle tissue.

AB - 1. Rates of protein synthesis have been measured from the incorporation of 57 mg of L-[1-C-13]leucine/kg for 90 min into muscle tissue and colorectal tumours removed at surgery from cancer patients.2. For the 20 h preceding surgery and during the measurement of protein synthesis, the patients received intravenous saline, conventional intravenous nutrition (0.2 g of N and 103 non-protein kJ/kg body weight) or intravenous nutrition enriched with the branched-chain amino acids leucine, isoleucine and valine (0.2 g of N with 30% from branched-chain amino acids and 103 non-protein kJ/kg body weight).3. Conventional intravenous nutrition resulted in a significant stimulation of the rate of protein synthesis in both muscle tissue (2.64+/-0.75%/day versus 1.78+/-0.51%/day in saline control, means+/-SD) and tumour tissue (43.9+/-10.3%/day versus 22.6+/-5.6%/day in saline control).4. Pre-operative nutrition enriched with branched-chain amino acids was less effective than conventional intravenous nutrition in stimulating protein synthesis in both muscle and tumour. The rates of protein synthesis were 2.12+/-0.41%/day in muscle and 33.7+/-5.3%/day in the tumours.5. The expression of proliferating cell nuclear antigen in sections of the tumours showed changes with intravenous feeding of the two different amino acid mixtures that were similar to the changes in protein synthesis, and these two variables were significantly correlated. This is evidence that feeding with conventional mixtures and mixtures enriched with branched-chain amino acids stimulates tumour growth.6. In this study the mixture enriched with branched-chain amino acids provided no clear advantage for cancer patients, since a smaller response to branched-chain amino acids was observed in both tumours and host muscle tissue.

KW - Branched-chain amino acids

KW - cancer

KW - isoleucine

KW - leucine

KW - muscle

KW - protein kinetics

KW - protein metabolism

KW - total parenteral nutrition

KW - tumor

KW - valine

KW - protein-synthesis

KW - skeletal-muscle

KW - turnover

KW - infusion

KW - trial

KW - <1-C-13>leucine

KW - stimulation

KW - modulation

M3 - Article

VL - 86

SP - 339

EP - 345

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 3

ER -